Clinical trial
Comparison of the ABSORBTM Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (XienceTM) in Acute ST-Elevation Myocardial Infarction
NCT01986803 is registered in ClinicalTrials.gov with ECRI bv as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the ABSORBTM Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (XienceTM) in Acute ST-Elevation Myocardial Infarction
- Lead sponsor
- ECRI bv
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 6, 2014
- Completion date
- September 21, 2017
- Enrollment
- 191 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
acute st segment elevation myocardial infarction